bioaccess® runs first-in-human medical device clinical trials across 19 countries. Each country page details its regulator, ethics-review pathway, ISO 14155 alignment, FDA-data eligibility under 21 CFR 812.28, and how it compares to US/EU on cost (~30% lower) and speed.